BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20136707)

  • 1. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors.
    Schnetzler G; Banks I; Kirby M; Zou KH; Symonds T
    J Sex Med; 2010 Mar; 7(3):1237-46. PubMed ID: 20136707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns: data from the nationwide Japanese population.
    Kimura M; Shimura S; Kobayashi H; Tai T; Chikano Y; Baba S; Kano M; Nagao K
    J Sex Med; 2012 Jun; 9(6):1649-58. PubMed ID: 22513057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study.
    Chevret-Méasson M; Lavallée E; Troy S; Arnould B; Oudin S; Cuzin B
    J Sex Med; 2009 Mar; 6(3):761-9. PubMed ID: 19143916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction.
    Rubio-Aurioles E; Reyes LA; Borregales L; Cairoli C; Sorsaburu S
    Curr Med Res Opin; 2013 Jun; 29(6):695-706. PubMed ID: 23540375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
    El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
    Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment.
    Symonds T; Dean JD; Carr A; Carlsson M; Marfatia A; Schnetzler G
    J Sex Med; 2011 May; 8(5):1463-71. PubMed ID: 21324090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care.
    Costa P; Grandmottet G; Mai HD; Droupy S
    J Sex Med; 2013 Jul; 10(7):1850-60. PubMed ID: 23679019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can an educational program optimize PDE5i therapy? A study of Canadian primary care practices.
    Brock G; Carrier S; Casey R; Tarride JE; Elliott S; Dugré H; Rousseau C; D'Angelo P; Defoy I
    J Sex Med; 2007 Sep; 4(5):1404-13. PubMed ID: 17634053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
    Moncada I; Martínez-Jabaloyas JM; Rodriguez-Vela L; Gutiérrez PR; Giuliano F; Koskimaki J; Farmer IS; Renedo VP; Schnetzler G
    J Sex Med; 2009 Dec; 6(12):3469-77. PubMed ID: 19796051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process.
    Vicari E; La Vignera S; Condorelli R; Calogero AE
    J Sex Med; 2010 Mar; 7(3):1247-53. PubMed ID: 19674252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study.
    Cairoli C; Reyes LA; Henneges C; Sorsaburu S
    Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class.
    Shindel AW
    J Sex Med; 2009 Sep; 6(9):2352-64; quiz 2365-6. PubMed ID: 19735356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction.
    Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
    J Sex Med; 2009 Dec; 6(12):3449-57. PubMed ID: 19686427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erection hardness score and its relationship to successful sexual intercourse.
    Goldstein I; Mulhall JP; Bushmakin AG; Cappelleri JC; Hvidsten K; Symonds T
    J Sex Med; 2008 Oct; 5(10):2374-80. PubMed ID: 18624971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
    Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R
    BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men.
    Bechara A; Casabé A; De Bonis W; Helien A; Bertolino MV
    J Sex Med; 2010 Nov; 7(11):3736-42. PubMed ID: 20722788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
    Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
    J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In men with erectile dysfunction, satisfaction with quality of erections correlates with erection hardness, treatment satisfaction, and emotional well-being.
    Kaminetsky JC; Depko AJ; Ströberg P; Buvat J; Tseng LJ; Stecher VJ
    J Sex Med; 2009 Mar; 6(3):800-8. PubMed ID: 19143914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
    Traish A; Kim N
    J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.